December 19, 2018 05:48 AM EST

GSK, Pfizer to create consumer health powerhouse under JV — then spin it out

Natalie Grover

Reporter

GlaxoSmithKline CEO Emma Walmsley took over the reins in 2017 with an unenviable task — to reverse the steadily eroding fortunes of the pharmaceutical giant. Her …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

GSK, Pfizer to create consumer health powerhouse under JV — then spin it out

Natalie Grover

Reporter

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

CBER's deputy director departs as staff shakeup continues

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

FDA approves first drug to treat ultra-rare lipid storage disease

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

GSK, Pfiz­er to cre­ate con­sumer health pow­er­house un­der JV — then spin it out

Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

GSK, Pfizer to create consumer health powerhouse under JV — then spin it out